BlackRock, Inc. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
BLACKROCK INC BLK |
332,384 3.400% |
-402,298 (-54.76%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BLACKROCK INC BLK |
734,682 7.500% |
30,405 (+4.32%) |
Filing |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
BLACKROCK INC BLK |
704,277 7.200% |
252,434 (+55.87%) |
Filing |